Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1997
12/02/1997US5693323 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
12/02/1997CA2057734C Oxidized-type glutathione alkyl ester
11/1997
11/30/1997CA2206674A1 Lactobacillus therapies
11/29/1997CA2187728A1 Iron-regulated metal transporters and uses therefor
11/27/1997WO1997044656A1 Compositions and methods for modulating type i interleukin-1 receptor expression
11/27/1997WO1997044493A1 Anti-paramyxovirus screening method and vaccine
11/27/1997WO1997044492A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
11/27/1997WO1997044479A1 Novel antitumor compounds and process for producing the same
11/27/1997WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997WO1997044467A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR
11/27/1997WO1997044466A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997WO1997044463A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
11/27/1997WO1997044462A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997WO1997044460A1 Modulators of tissue regeneration
11/27/1997WO1997044457A1 Polycystic kidney disease gene
11/27/1997WO1997044456A2 Tumor virus susceptibility genes and gene products, and uses related thereto
11/27/1997WO1997044455A1 Hematopoietic cytokine receptor
11/27/1997WO1997044454A2 Human phospholipase inhibitor
11/27/1997WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997WO1997044452A1 Human b-cell antigens, related reagents
11/27/1997WO1997044451A2 Vasoactive amine binding molecules
11/27/1997WO1997044449A1 Promoters for swine complement inhibitors
11/27/1997WO1997044445A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents
11/27/1997WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997WO1997044440A1 Cell line
11/27/1997WO1997044362A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
11/27/1997WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997WO1997044358A1 Zona pellucida proteins for contraception
11/27/1997WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997WO1997044354A2 Synthesis of soluble beta-sheet forming peptides
11/27/1997WO1997044353A1 Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections
11/27/1997WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997WO1997044351A1 Immunomodulating dimers
11/27/1997WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
11/27/1997WO1997044348A1 Ribozyme-mediated gene replacement
11/27/1997WO1997044347A1 Human cis protein
11/27/1997WO1997044346A2 Specific inhibitors of dna methyltransferase enzyme
11/27/1997WO1997044135A1 Fibrinogen apparatus, method and container
11/27/1997WO1997044061A1 Aspergillus fumigatus lectin and methods of using same
11/27/1997WO1997044059A2 Cartilage type ii collagen as an angiogenic factor
11/27/1997WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997WO1997044056A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
11/27/1997WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997WO1997044050A1 Human calcium sensor protein, fragments thereof and dna encoding same
11/27/1997WO1997044046A1 Platelet-derived growth factor expression inhibitor
11/27/1997WO1997044024A1 Novel arachidonic acid metabolite, 16-hete
11/27/1997WO1997044015A1 Microparticles and their use in wound therapy
11/27/1997WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997WO1997040170A3 Functional expression of heterologous adenylyl cyclase
11/27/1997WO1997039738A3 Sustained release ionic conjugate
11/27/1997WO1997039102A3 Secreted proteins
11/27/1997WO1997035976A3 Epidermal differentiation factor
11/27/1997WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997WO1997031107A3 Human serum lectin - induced apoptosis and method for detecting apoptosis
11/27/1997DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997DE19622289A1 Zona Pellucida Proteine zur Kontrazeption Zona pellucida proteins for contraception
11/27/1997CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997CA2257791A1 Fibrinogen apparatus, method and container
11/27/1997CA2256589A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
11/27/1997CA2256578A1 Novel arachidonic acid metabolite, 16-hete
11/27/1997CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997CA2256465A1 Blocking expression of virulence factors in s. aureus
11/27/1997CA2256338A1 Zona pellucida proteins for contraception
11/27/1997CA2256305A1 Specific inhibitors of dna methyltransferase enzyme
11/27/1997CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997CA2255712A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997CA2255579A1 Mitogen-activated protein kinase p38-2 and methods of use therefor
11/27/1997CA2255572A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997CA2254843A1 Human b-cell antigens, related reagents
11/27/1997CA2254083A1 Polycystic kidney disease gene
11/27/1997CA2253934A1 Inhibitors of protein farnesyl transferase
11/27/1997CA2253541A1 Human phospholipase inhibitor
11/27/1997CA2227171A1 Icea gene and related methods
11/26/1997EP0808905A2 Adenoviral vector for the transfer of human genes in vivo
11/26/1997EP0808904A2 Interleukin-1 beta converting enzyme like apoptotic protease-6
11/26/1997EP0808902A2 Novel genes encoding antiviral proteins of Phytolacca insularis Nakai and recombinant microorganisms expressing the same proteins
11/26/1997EP0808901A2 Pharmaceutical preparation with factor VIII procoagulant activity and vWF-binding activity
11/26/1997EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
11/26/1997EP0808899A2 Human marco scavenger receptor (HMarcoSR)
11/26/1997EP0808898A1 Reagent and method for inhibition of N-ras expression
11/26/1997EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/26/1997EP0808846A2 Peptides which react with antiboby representing the prognostic marker for HIV disease progression
11/26/1997EP0808844A2 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells
11/26/1997EP0808630A1 Cancer control
11/26/1997EP0808375A1 Lil-stat dna binding sites and methods for identifying inhibitory binding agents
11/26/1997EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997EP0808367A1 Mucosal vascular addressins and uses thereof
11/26/1997EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
11/26/1997EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997EP0808364A1 Human pancreatic cell lines: developments and uses
1 ... 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 ... 3163